Literatur
Wilt TJ et al. N Engl J Med. 2017;377(2):132–142.
Bill-Axelson A et al. N Engl J Med. 2011;364(18):1708–17.
Hamdy FC et al. N Engl J Med. 2016;375(15):1415–24.
Warde P et al. Lancet. 2011;378(9809):2104–11.
Widmark A et al. Lancet. 2009;373(9660):301–8.
Bolla M et al. Lancet Oncol. 2010;11(11):1066–73.
Fizazi K et al. Lancet Oncol. 2015;16(7):787–94.
James ND et al. N Engl J Med. 2017;377(4):338–351.
James ND et al. JAMA Oncol. 2016;2(3):348–57.
Rusthoven CG et al. J Clin Oncol. 2016;34(24):2835–42.
Donovan JL et al. N Engl J Med. 2016;375(15):1425–37.
Resnick MJ et al. N Engl J Med. 2013;368(5):436–45.
Erstpubliziert in Strahlenther Onkol. 2017;194(2):174-77.
Wilt TJ et al. Follow-up of Prostatectomy versus Observation for Early Prostate Cancer. N Engl J Med. 2017; 377(2):132–42.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kroeze, S., Fritz, C. & Guckenberger, M. Wer profitiert von welchem lokalen Vorgehen?. Info Onkol. 21, 32–34 (2018). https://doi.org/10.1007/s15004-018-6095-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15004-018-6095-3